Oral Lesions in HIV-Positive Patients:A Retrospective Study from aHistopathology Service
DOI:
https://doi.org/10.5335/rfo.v30i1.17742Palavras-chave:
Acquired Immunodeficiency Syndrome, Human Immunodeficiency Virus, Oral lesions, StomatologyResumo
Aim: HIV-associated oral lesions may serve as predictive indicators of immunosuppression, assisting in
both the diagnosis and monitoring of disease progression in affected patients. Therefore, this study aimed
to retrospectively analyse biopsied HIV-associated oral lesions diagnosed by a specialised histopathology
service, with emphasis on patient and lesion characteristics. Materials and methods: A retrospective
cross-sectional study was conducted to analyse cases of HIV-associated oral lesions from the DCOD,
covering records from January 1981 to December 2024. Results: Among the 26,947 reports analysed, 83
were suggestive of HIV-associated lesions, of which 24 patients had confirmed infection. Kaposi sarcoma
and non-Hodgkin lymphoma were the most frequent diagnoses. Most patients were male (75%), with a
mean age of 46 years (SD = 14.91). Conclusion: This retrospective study met its objectives by
characterising the demographic profile of affected patients and describing the clinical features of
HIV-associated oral lesions diagnosed at a regional referral centre
Downloads
Referências
1. World Health Organization. HIV/AIDS: fact sheet. 2023. Available at
https://www.who.int/news-room/fact-sheets/detail/hiv-aids (accessed April 2025).
2. Le Hingrat Q, Sereti I, Landay AL, Pandrea I, Apetrei C. The Hitchhiker Guide to
CD4+ T-Cell depletion in lentiviral infection. A critical review of the dynamics of the
CD4+ T Cells in SIV and HIV infection. Front Immunol 2021; 12:695674.
3. Mwangosi IEAT, Tillya J. Oral lesions associated with HIV/AIDS in HIV-seropositive
patients attending a counselling and treatment centre in Dar es Salaam. Int Dent J.
2012; 62(4):197-202.
4. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO
Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus.
Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med.
1993; 22(7):289-91.
5. Indrastiti RK, Wardhany II, Soegyanto AI. Oral manifestations of HIV: Can they be an
indicator of disease severity? (A systematic review). Oral Dis. 2020; 26(Suppl.
1):133-136.
6. UNAIDS. Global HIV & AIDS statistics — Fact sheet. 2024. Available at:
https://www.unaids.org/en/resources/fact-sheet (accessed April 2025).
7. Brazilian Ministry of Health - Department of HIV/AIDS, Tuberculosis, Viral Hepatitis
and Sexually Transmitted Infections. Epidemiological Bulletin HIV and AIDS 2024.
Ministry of Health; 2024.
8. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART
in industrialized countries. Adv Dent Res. 2006; 19(1):57-62.
9. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP,
STROBE Initiative. The Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting observational studies. J
Clin Epidemiol. 2008; 61:344-9.
10. El Howati A, Tappuni A. Systematic review of the changing pattern of the oral
manifestations of HIV. J Invest Clin Dent. 2018; 9:e12351.
11. Chen Y, Li A, Yang Y, Lu J, Xu Y, Ji X, et al. Global, regional and national burden of
HIV/AIDS among individuals aged 15-79 from 1990 to 2021. AIDS Res Ther. 2025;
22(1):51.
12. Arendorf TM, Bredekamp B, Cloete CAC, Sauer G. Oral manifestations of HIV
infection in 600 South African patients. J Oral Pathol Med. 1998; 27(4):176-9.
13. Fabian FM, Kahabuka FK, Petersen PE, Shubi FM, Jürgensen N. Oral
manifestations among people living with HIV/AIDS in Tanzania. Int Dent J. 2009;
59(4):187-91.
14. Berberi A, Noujeim Z. Epidemiology and relationships between CD4+ counts and
oral lesions among 50 patients infected with human immunodeficiency virus. J Int Oral
Health. 2015; 7(1):18-21.
15. Souza BKL, Faé DS, Lemos CAA, Verner FS, Machado RA, Ortega RM, Aquino
SN. Associated oral manifestations with HIV southeastern Brazilian patients on
antiretroviral therapy. Braz J Otorhinolaryngol. 2023; 89:425-31.
16. Moniaci D, Greco D, Flecchia G, Raiteri R, Sinicco A. Epidemiology, clinical
features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med. 1990;
19:477-81.
17. Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KAAS.
Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral
therapy (HAART) in South London. J Oral Pathol Med. 2002; 31(3):169-74.
18. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G,
González-Ramírez I, Ponce-de-León S. The changing clinical spectrum of human
immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a
12-year study in a referral center in Mexico. Medicine (Baltimore). 2003; 82(1):39-50.
19. Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in
HIV infected patients: a study in Brazil. Int Dent J. 2004; 54(3):131-7.
20. Tirwomwe JF, Rwenyonyi CM, Muwazi LM, Besigye B, Mboli F. Oral manifestations
of HIV/AIDS in clients attending TASO clinics in Uganda. Clin Oral Invest. 2007;
11:289-92.
21. Lourenço AG, Motta ACF, Figueiredo LTM, Machado AA, Komesu MC. Oral lesions
associated with HIV infection before and during the antiretroviral therapy era in
Ribeirão Preto, Brazil. J Oral Sci. 2011; 53(3):379-85.
22. Bartholo MF, Tenório JR, Andrade NS, Shibutani PP, Martins F, Gallottini M.
Orofacial manifestations in Brazilian people living with HIV/AIDS under long-term
antiretroviral therapy: a cross-sectional study. Oral Surg Oral Med Oral Pathol Oral
Radiol. 2023; 136(4):436-441.
23. Borges ÁH. Combination antiretroviral therapy and cancer risk. Curr Opin HIV
AIDS. 2017; 12(1):12-9.
24. Chen Y, Zhao J, Sun P, Cheng M, Xiong Y, Sun Z, et al. Estimates of the global
burden of non-Hodgkin lymphoma attributable to HIV: a population attributable
modeling study. eClinicalMedicine. 2024; 67:102370
25. Barone S, Buffone C, Ferrillo M, Pasqua F, Parrotta S, Salviati M, et al. Oral
malignant non-Hodgkin lymphoma: A retrospective single-center study. Int J Environ
Res Public Health. 2022; 19(5):2605.
26. Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D.
Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment
including protease inhibitors: A new face of oral AIDS? AIDS Patient Care STDs. 2000;
14(12):627-35.
27. Zhang X, Reichart PA, Song Y. Oral manifestations of HIV/AIDS in China: a review.
Oral Maxillofac Surg. 2009; 13(1):63–8.
28. De Arruda JAA, Schuch LF, Neto NC, de Souza LL, Rodrigues-Fernandes CI,
Abreu LG, et al. Oral and oropharyngeal lymphomas: a multi-institutional collaborative
study. J Oral Pathol Med. 2021; 50(7):717-26.
29. Gómez B L. Histoplasmosis: Epidemiology in Latin America. Curr Fungal Infect
Rep. 2011; 5(4):199-205.
30. Cano-Torres J O, Olmedo-Reneaum A, Esquivel-Sánchez J M, Camiro-Zuñiga A,
Pérez-Carrisoza A, Madrigal-Iberri C, et al. Progressive disseminated histoplasmosis in
Latin America and the Caribbean in people receiving highly active antiretroviral therapy
for HIV infection: A systematic review. Med Mycol. 2019; 0:1-9.
31. Falci D R, Dalla Lana D F, Pasqualotto A C. The era of histoplasmosis in Brazilian
endemic mycoses. Lancet Reg Health Am. 2021; 3:100037.
32. Folk GA, Nelson BL. Oral Histoplasmosis. Head Neck Pathol. 2017; 11(4):513-6.
33. Ceccarelli M, Rullo E V, Facciolà A, Madeddu G, Cacopardo B, Taibi R, et al. Head
and neck squamous cell carcinoma and its correlation with human papillomavirus in
people living with HIV: a systematic review. Oncotarget. 2018; 9(24):17171-80.
34. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly
active antiretroviral therapy on frequency of oral warts. Lancet. 2001;
357(9266):1411–2.
35. King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM.
Human Papillomavirus-Associated Oral Warts among Human Immunodeficiency
Virus-Seropositive Patients in the Era of Highly Active Antiretroviral Therapy: An
Emerging Infection. Clin Infect Dis. 2002; 34(5):641–8.
36. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE.
Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 2007; 103(suppl 1):S50.e1-S50.e23.
Publicado
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Este periódico bem como seus artigos estão licenciados com a licença Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional.
